ComplianceOnline

Class I Recall of Stroke Catheter (Penumbra System Reperfusion Catheter 032)

  • Date: December 15, 2010
  • Source: Admin
Access Regulatory Compliance Training sessions led by expert panelists below.

Compliance Webinars | Virtual Seminars for Professionals

A stroke is a rapidly developing loss of brain function occasioned by interrupted blood supply to the brain. As a result, the affected area of the brain is unable to function. A stroke is a medical emergency and can cause permanent damage.

Why the recall?

The recall was issued because mid-shaft joint failures were noticed in some Reperfusion Catheters 032, belonging to lot F15020.  Such defective devices may prevent the flow of blood to the brain causing serious injury to or death of patients. The recall applied to 77 devices of which 28 were sold in the U.S. Healthcare professionals and costumers in possession of the recalled device were advised to discontinue its use.

Regulations

The FDA has jurisdiction over food, drugs, cosmetics, medical devices and other products and monitors product recalls. In most cases, recalls are voluntarily initiated by the manufacturer, when the manufacturer discovers that it is defective. In others, the FDA will notify the manufacturer of the defective product and suggest a recall.

FDA guidelines categorize all recalls into one of the following three classes according to the hazard level:
 

  • Class I recalls for dangerous or defective products that could cause serious health problems or death.
  • Class II recalls for products that might cause a temporary health problem, or pose only a slight threat of a serious nature.
  • Class III recalls for products that are unlikely to cause any adverse health reaction, but violate FDA regulations.
Source:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm236155.htm
http://en.wikipedia.org/wiki/Stroke
http://www.medterms.com/script/main/art.asp?articlekey=10552
 

 

Trending Compliance Trainings

Trial Master File and Clinical Data Management Regulated by FDA
By - Carolyn Troiano
On Demand Access Anytime
Good Documentation Practice and Record Keeping Regulations (FDA & EMA)
By - Dr. Afsaneh Motamed Khorasani
On Demand Access Anytime
GAMP Data Integrity 21 CFR Part 11 Training Course
By - Kelly Thomas
On Demand Access Anytime
NEW Reclamation Process - Fed Gov't Payments
By - Donna K Olheiser
On Demand Access Anytime
Understanding and Preparing for FDA Pharmaceutical Inspections
By - Michael Ferrante
On Demand Access Anytime
How to conduct an effective BSA Audit
By - Justin Muscolino
On Demand Access Anytime
Installation and Qualification of the Packaging Lines
By - John E Lincoln
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading